FE 999904

Drug Profile

FE 999904

Alternative Names: FE 999 904; HP hCG; Human chorionic gonadotropin - Ferring Pharmaceuticals

Latest Information Update: 26 Mar 2009

Price : *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Ferring Pharmaceuticals
  • Class Infertility therapies; Peptide hormones; Pituitary gonadotropins
  • Mechanism of Action Chorionic gonadotropin stimulants; Ovarian follicle stimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No

Highest Development Phases

  • No development reported Female infertility

Most Recent Events

  • 26 Mar 2009 No development reported - Phase-I for Female infertility in USA (unspecified route)
  • 08 Nov 2006 Phase I development is ongoing for Female infertility
  • 14 Oct 2004 Phase-I clinical trials in Female infertility in USA (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top